Biomarkers of oxidative stress

Systems Biology of Free Radicals and Antioxidants

Volumn 9783642300189, Issue , 2014, Pages 65-87

  Lowe, Frazer ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Antioxidants; Biomarkers; Cancer; Chronic disease; Inflammation; Oxidative stress

Indexed keywords

EID: 84949175754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-30018-9_4     Document Type: Chapter

References (152)

1. Alam MM, O'Neill LA (2011) MicroRNAs and the resolution phase of inflammation in macrophages. Eur J Immunol 41:2482-2485
2. Andreoli R, Manini P, Corradi M, Mutti A, Niessen WM (2003) Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 17:637-645
3. Awad JA, Morrow JD, Takahashi K, Roberts LJ (1993) Identification of non-cyclooxygenasederived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem 268:4161-4169
4. Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, Sparrow D, Vokonas P, Schwartz J (2010) Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 21:819-828
5. Balasubramanian B, Pogozelski WK, Tullius TD (1998) DNA strand breaking by the hydroxyl radical is governed by the accessible surface areas of the hydrogen atoms of the DNA backbone. Proc Natl Acad Sci 95(17):9738-9743
6. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72:141-196
7. Berry EM, Kohen R (1999) Is the biological antioxidant system integrated and regulated? Med Hypotheses 53:397-401
8. Brussino L, Badiu I, Sciascia S, Bugiani M, Heffler E, Guida G, Malinovschi A, Bucca C, Rolla G (2010) Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis. Clin Exp Allergy 40(11):1642-1647. doi:10.1111/j.1365-2222.2010.03604.x. Epub 2010 Aug 18
9. Bussemaker HJ, Ward LD, Boorsma A (2007) Dissecting complex transcriptional responses using pathway-level scores based on prior information. BMC Bioinformatics 8:S6
10. Cao G, Prior RL (1998) Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 44:1309-1315
11. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ (2004) Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 59:1016-1019
12. Carpenter CT, Price PV, Christman BW (1998) Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 114:1653-1659
13. Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J (2010) Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease. Expert Rev Neurother 10:925-942
14. Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527-605
15. Charames GS, Bapat B (2003) Genomic instability and cancer. Curr Mol Med 3:589-596
16. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G ! T and A ! C substitutions. J Biol Chem 267:166-172
17. Cheung HH, Lee TL, Rennert OM, Chan WY (2009) DNA methylation of cancer genome. Birth Defects Res C Embryo Today 87:335-350
18. Clayson DB (1994) Mechanistic and other considerations in cancer prevention. Cancer Lett 83:15-19
19. Commoner B, Townsend J, Pake G (1954) Free radicals in biological materials. Nature 174:689-691
20. Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ (1997) The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev 6:907-916
21. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
22. Cooke MS, Olinski R, Evans MD (2006) Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 365:30-49
23. Cookson MR, Shaw PJ (1999) Oxidative stress and motor neurone disease. Brain Pathol 9:165-186
24. Cracowski JL, Devillier P, Durand T, Stanke-Labesque F, Bessard G (2001) Vascular biology of the isoprostanes. J Vasc Res 38:93-103
25. Davey JW, Hohenlohe PA, Etter PD, Boone JQ, Catchen JM, Blaxter ML (2011) Genome-wide genetic marker discovery and genotyping using next-generation sequencing. Nat Rev Genet 12:499-510
26. Davies SS, Roberts LJ 2nd (2011) F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med 50:559-566
27. Donkena KV, Young CY, Tindall DJ (2010) Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int 2010:302051
28. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
29. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011) Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J 9:2474-2756
30. Evans J, Maccabee M, Hatahet Z, Courcelle J, Bockrath R, Ide H, Wallace S (1993) Thymine ring saturation and fragmentation products: lesion bypass, misinsertion and implications for mutagenesis. Mutat Res 299(3-4):147-56
31. Evans MD, Griffiths HR, Lunec J (1997) Reactive oxygen species and their cytotoxic mechanisms. In: Chipman JK (ed) Mechanisms of cell toxicity, 20th edn. JAI Press, London, pp 25-73
32. Farinati F, Cardin R, Degan P, De Maria N, Floyd RA, Van Thiel DH, Naccarato R (1999) Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med 27:1284-1291
33. Ferrari R, Ceconi C, Curello S, Cargnoni A, Pasini E, De Giuli F, Albertini A (1991) Role of oxygen free radicals in ischemic and reperfused myocardium. Am J Clin Nutr 53:215S-222S
34. Fleming TR, DeMets DL (1996) Surrogate endpoints in clinical trials: are we being mislead? Ann Intern Med 125(7):605-613
35. Gaber A, Tamoi M, Takeda T, Nakano Y, Shigeoka S (2001) NADPH-dependent glutathione peroxidase-like proteins (Gpx-1, Gpx-2) reduce unsaturated fatty acid hydroperoxides in Synechocystis PCC 6803. FEBS Lett 499:32-36
36. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, Kirkman HN (1996) Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 87:1595-1599
37. GenestraM(2007) Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19:1807-1819
38. Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29:1106-1114
39. Gilad S, Meiri E, Yogev Y et al (2008) Serum MicroRNAs are promising novel biomarkers. PLoS One 3:e3148
40. Gitan RS, Shi H, Chen C-M, Yan PS, Huang TH-M (2002) Methylation-specific oligonucleotide microarray: A new potential for high-throughput methylation analysis. Genome Res 12:158-164
41. Goessl C, Müller M, Straub B, Miller K (2002) DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur Urol 41:668-676
42. Golden TR, Patel M (2009) Catalytic antioxidants and neurodegeneration. Antioxid Redox Signal 11:555-570
43. Goodsaid FM, Frueh FW, Mattes W (2008) Strategic paths for biomarker qualification. Toxicology 245:219-223
44. Gregory EM, Fridovich I (1973) Oxygen toxicity and the superoxide dismutase. J Bacteriol 114:1193-1197
45. Grune T, Schröder P, Biesalski HK (2005) Low molecular weight antioxidants. In: The handbook of environmental chemistry, 2nd edn. Springer, Berlin, pp 185-350
46. Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685-716
47. Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231-255
48. Han W, Wang T, Reilly AA, Keller SM, Spivack SD (2009) Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res 10:86
49. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
50. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS (2006) Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 8(4):600-622
51. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51-88
52. Henderson PT, Delaney JC, Gu F, Tannenbaum SR, Essigmann JM (2002) Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry 41:914-921
53. Hitchon CA, El-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthritis Res Ther 6:265-278
54. Hori M, Yonei S, Sugiyama H, Kino K, Yamamoto K, Zhang Q-M (2003) Identification of high expression capacity for 5-hydroxymethyluracil mispaired with guanine in DNA of E. coli MutM, Nei and Nth DNA glycosylases. Nucleic Acids Res 31:1191-1196
55. Hulsmans M, De Keyzer D, Holvoet P (2011) MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 25(8):2515-2527
56. Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: The interrelationship between genetics and epigenetics. Carcinogenesis 29:673-680
57. Institute of Medicine (2010) Evaluation of biomarkers and surrogate endpoints in chronic disease. In: Micheel CM, Ball JR (eds). National Academies Press, Washington, DC, ISBN-10:0-309-15129-5. http://www.nap.edu/catalog.php?record-id=12869
58. Institute of Medicine (2011) Perspectives on biomarker and surrogate endpoint evaluation: discussion forum summary. In: Mack A, Balogh E, Micheel C (eds). National Academies Press, Washington, DC. ISBN-10: 0-309-16324-2. http://www.nap.edu/catalog.php?record-id=13038#toc
59. Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067-L1082
60. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1080
61. Jeppesen DK, Bohr VA, Stevnsner T (2011) DNA repair deficiency in neurodegeneration. Prog Neurobiol 94:166-200
62. Kamiya H, Tsuchiya H, Karino N, Veno Y, Matsuda A, Harashima H (2002) Mutagenicity of 5-formylcytosine, an oxidation product of 5-methylcytosine in DNA in mammalian cells. J Biochem 132:551-555
63. Kang KA, Zhang R, Kim GY, Bae SC, Hyun JW (2012) Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol 33(2):403-412
64. Kapronov P, Drenkow J, Cheng J, Long J, Helt G, Dike S, Gingeras TR (2005) Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Res 15:987-997
65. Khan MA, Tania M, Zhang D, Chen H (2010) Antioxidant enzymes and cancer. Chin J Cancer Res 22:87-92
66. Kohen R, Nyska A (2002) Invited review: oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620-650
67. Kohen R, Moor E, Oron M (2003) Measurements of biological reducing power by voltammetric methods. In: Packer L, Podder M, Fuchs J (eds) Redox genome interaction in health and disease. Marcel Dekker, New York, pp 13-42
68. Kurien BT, Hensley K, Bachmann M, Scofield RH (2006) Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 41:549-556
69. Langevin SM, Koestler DC, Christensen BC, Butler RA, Wiencke JK, Nelson HH, Houseman EA, Marsit CJ, Kelsey KT (2012) Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study. Epigenetics 7:291-299
70. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854
71. Lewin B (1997) Genes, 6th edn. Oxford University Press, New York
72. Liebler DC, Reed DJ (1999) Free radical defence and repair mechanisms. In: Wallance KB (ed) Free radical toxicology. Publisher Press, New York, pp 490-495
73. Lim SO, Gu JM, Kim MS, Kim HS, Park YM, Park CK, Cho JW, Park YM, Jung G (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135:2128-2140
74. Liu W, Morrow JD, Yin H (2009) Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 47:1101-1107
75. Louhelainen N, Rytilä P, Obase Y, Mäkelä M, Haahtela T, Kinnula VL, Pelkonen A (2008) The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma. J Asthma 45:149-154
76. Lowe FJ, Gregg EO, McEwan M (2009) Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clin Chem Lab Med 47:311-320
77. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 9;435(7043):834-838
78. Lykkesfeldt J (2007) Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomarkers Prev 16:2513-2516
79. Mäder U, Nicolas P, Richard H, Bessières P, Aymerich S (2011) Comprehensive identification and quantification of microbial transcriptomes by genome-wide unbiased methods. Curr Opin Biotechnol 22:32-41
80. Maier CM, Chan PH (2002) Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8:323-334
81. Makris D, Paraskakis E, Korakas P, Karagiannakis E, Sourvinos G, Siafakas NM, Tzanakis N (2008) Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 75:138-144
82. Makropoulos W, Kocher K, Heintz B, Schwarz ER, Mertens PR, Stefanidis I (2000) Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation. Ren Fail 22:499-510
83. Mannervik B (1985) The isozymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 57:357-417
84. Marnett LJ (2000) Oxyradicals and DNA damage. Carcinogenesis 21:361-370
85. Martinez-Pinna R, Barbas C, Blanco-Colio LM, Tunon J, Ramos-Mozo P, Lopez JA, Meilhac O, Michel JB, Egido J, Martin-Ventura JL (2010) Proteomic and metabolomic profiles in atherothrombotic vascular disease. Curr Atheroscler Rep 12:202-208
86. Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B (2011) A generic operational strategy to qualify translational safety biomarkers. Drug Discov Today 16:600-608
87. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454:766-770
88. Meister A (1988) Glutathione metabolism and its selective modification. J Biol Chem 263(33):17205-17208
89. Michel F, Bonnefont-Rousselot D, Mas E, Drai J, Thérond P (2008) Biomarkers of lipid peroxidation: analytical aspects [article in French]. Ann Biol Clin (Paris) 66:605-620
90. Milbury P, Blumberg JB (2003) Dietary antioxidants - human studies overview. In: Rodriguez H, Cutler RG (eds) Critical reviews of oxidative stress and aging: advances in basic science, diagnostics, and intervention. World Scientific Publishing, River Edge, pp 487-502
91. Milne GL, Yin H, Brooks JD, Sanchez S, Jackson Roberts L 2nd, Morrow JD (2007) Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 433:113-126
92. Milne GL, Yin H, Morrow JD (2008) Human biochemistry of the isoprostane pathway. J Biol Chem 283:15533-15537
93. Montuschi P, Barnes PJ, Ciabattoni G (2010) Measurement of 8-isoprostane in exhaled breath condensate. Methods Mol Biol 594:73-84
94. Morrow JD, Roberts LJ (1994) Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol 233:163-174
95. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II (1990a) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
96. Morrow JD, Harris TM, Roberts LJ II (1990b) Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 184:1-10
97. Morrow JD, Awad JA, Kato T, Takahashi K, Badr DF, Roberts LJ, Burk RF (1992) Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J Clin Invest 90:2502-2507
98. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 332:1198-1203
99. Nishibe A, Kijima Y, Fukunaga M, Nishiwaki N, Sakai T, Nakagawa Y, Hata T (2008) Increased isoprostane content in coronary plaques obtained from vulnerable patients. Prostaglandins Leukot Essent Fatty Acids 78:257-263
100. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih IM, Vogelstein B, Lengauer C (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99:16226-16231
101. Ohshima H, Pignatelli B, Li CQ, Baflast S, Gilibert I, Boffetta P (2002) Analysis of oxidized and nitrated proteins in plasma and tissues as biomarkers for exposure to reactive oxygen and nitrogen species. IARC Sci Publ 156:393-394
102. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Hammer S (1996) Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. New Eng J Med 334:1150-1155
103. Patrono C, Falco A, Davì G (2005) Isoprostane formation and inhibition in atherothrombosis. Curr Opin Pharmacol 5:198-203
104. Peto R, Doll R, Buckley JD, Sporn MB (1981) Can dietary beta-carotene materially reduce human lung cancer rates? Nature 290:201-208
105. Pilger A, Rüdiger HW (2006) 8-Hydroxy-20-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 80:1-15
106. Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138:2059-2072
107. Praticò D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP, Iuliano L, Rokach J, FitzGerald GA (1998a) IPF2a-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci USA 95:3449-3454
108. Praticò D, Basili S, Vieri M, Cordova C, Violi F, FitzGerald GA (1998b) Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2a-III, an index of oxidant stress. Am J Respir Crit Care Med 158:1709-1714
109. Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 27:1173-1181
110. Ramírez MJ, Puerto S, Galofré P, Parry EM, Parry JM, Creus A, Marcos R, Surrallés J (2000) Multicolour FISH detection of radioactive iodine-induced 17cen-p53 chromosomal breakage in buccal cells from therapeutically exposed patients. Carcinogenesis 21:1581-1586
111. Reilly M, Delanty N, Lawson JA, FitzGerald GA (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19-25
112. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA (1997) Increased formation of the isoprostanes IPF2a-I and 8-epi-prostaglandin F2a in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96:3314-3320
113. Robaey P, Krajinovic M, Marcoux S, Moghrabi A (2008) Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy. Dev Disabil Res Rev 14:211-220
114. Saha S, Sparks AB, Rago C, Akmaev V, Wang CJ, Vogelstein B, Kinzler KW, Velculescu VE (2002) Using the transcriptome to annotate the genome. Nat Biotechnol 20:508-512
115. Sastre J, Serviddio G, Pereda J, Minana JB, Arduini A, Vendemiale G, Poli G, Pallardo FV, Vina J (2007) Mitochondrial function in liver disease. Front Biosci 12:1200-1209
116. Schaffert CS (2011) Role of MGST1 in reactive intermediate-induced injury. World J Gastroenterol 17:2552-2557
117. Serafini M, Villano D, Spera G, Pellegrini N (2006) Redox molecules and cancer prevention: The importance of understanding the role of the antioxidant network. Nutr Cancer 56:232-240
118. Serretti A, Olgiati P, De Ronchi D (2007) Genetics of Alzheimer's disease. A rapidly evolving field. J Alzheimers Dis 12:73-92
119. Shenker N, Flanagan JM (2012) Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research. Br J Cancer 106:248-253
120. Shi H, Wang MX, Caldwell CW (2007) CpG islands: their potential as biomarkers for cancer. Expert Rev Mol Diagn 7:519-531
121. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H (1994) Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 54:3171-3172
122. Smith DJ (2009) Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics. J Bioenerg Biomembr 41:487-491
123. Sofia M, Maniscalco M, De Laurentiis G, Paris D, Melck D, Motta A (2011) Exploring airway diseases by NMR-based metabonomics: A review of application to exhaled breath condensate. J Biomed Biotechnol 2011:Article ID 403260
124. Somogyi A, Rosta K, Pusztai P, Tulassay Z, Nagy G (2007) Antioxidant measurements. Physiol Meas 28:R41-R55
125. Sookoian S, Pirola CJ (2011) Metabolic syndrome: from the genetics to the pathophysiology. Curr Hypertens Rep 13:149-157
126. Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, Bonventre JV, Prescott SM, Roberts LJ 2nd (2006) Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 281:4616-4623
127. Staszel T, Zapała B, Polus A, Sadakierska-Chudy A, Kieć-Wilk B, Stępień E, Wybrańska I, Chojnacka M, Dembińska-Kieć A (2011) Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 121:361-366
128. Steiling K, Ryan J, Brody JS, Spira A (2008) The field of tissue injury in the lung and airway. Cancer Prev Res (Phila) 1:396-403
129. Stephens JW, Khanolkar MP, Bain SC (2009) The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202:321-329
130. Tan SH, Lee SC, Goh BC, Wong J (2008) Pharmacogenetics in breast cancer therapy. Clin Cancer Res 14:8027-8041
131. Taupin P (2010) A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. Cent Nerv Syst Agents Med Chem 10:16-21
132. Thier R, Brüning T, Kocher K, Blaszkewicz M, Makropoulos V, Sundberg A, Bolt HM (1999) Determination of urinary thymidine glycol using affinity chromatography, HPLC and post-column reaction detection: A biomarker of oxidative DNA damage upon kidney transplantation. Arch Toxicol 73:479-484
133. Tinahones FJ, Murri-Pierri M, Garrido-Sánchez L, García-Almeida JM, García-Serrano S, García-Arnés J, García-Fuentes E (2009) Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity 17:240-246
134. Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995) Persistent oxidative stress in cancer. FEBS Lett 358:1-3
135. Umetani N, de Maat MF, Sunami E, Hiramatsu S, Martinez S, Hoon DS (2006) Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation. Mol Cancer Res 4:303-309
136. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (2011) Guidance for industry: E16 biomarkers related to drug or biotechnology product development: context, structure, and format of qualification submissions. Food and Drug Administration, Silver Spring
137. Valavanidis A, Vlachogianni T, Fiotakis K (2009) Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 6:445-462
138. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266:37-56
139. Van Kooten F, Ciabattoni G, Patrono C, Dippel DW, Koudstaal PJ (1997) Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke 28:1557-1563
140. Varella-Garcia M, Schulte AP, Wolf HJ, Feser WJ, Zeng C, Braudrick S, Yin X, Hirsch FR, Kennedy TC, Keith RL, Barón AE, Belinsky SA, Miller YE, Byers T, Franklin WA (2010) The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) 3:447-453
141. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC (2004) Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 256:308-315
142. Vineis P, Husgafvel-Pursiainen K (2005) Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 26:1846-1855
143. Voulgaridou GP, Anestopoulos I, Franco R, Panayiotidis MI, Pappa A (2011) DNA damage induced by endogenous aldehydes: current state of knowledge. Mutat Res 711:13-27
144. Wallace SS (2002) Biological consequences of free radical-damaged DNA bases. Free Radic Biol Med 33:1-14
145. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y (2006) Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 184:425-430
146. Whaley-Connell A, McCullough PA, Sowers JR (2011) The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 12:21-29
147. Yamanaka K, Mizoi M, Tachikawa M, Hasegawa A, Hoshino M, Okada S (2003) Oxidative DNA damage following exposure to dimethylarsinous iodide: The formation of cis-thymine glycol. Toxicol Lett 143:145-153
148. Yang IA, Relan V, Wright CM, Davidson MR, Sriram KB, Savarimuthu Francis SM, Clarke BE, Duhig EE, Bowman RV, Fong KM (2011) Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15:439-456
149. Young IS (2001) Measurement of total antioxidant capacity. J Clin Pathol 54:339
150. Yuzhalin AE, Kutikhin AG (2012) Inherited variations in the SOD and GPX gene families and cancer risk. Free Radic Res 46:581-599
151. Ziech D, Franco R, Pappa A, Panayiotidis MI (2011) Reactive oxygen species (ROS) - induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711:167-173
152. Zukiel R, Nowak S, Barciszewska AM, Gawronska I, Keith G, Barciszewska MZ (2004) A simple epigenetic method for the diagnosis and classification of brain tumors. Mol Cancer Res 2(3):196-202